Morrison Briggs Insider Trading Activity

Average Profitability
19.73%
Insider Buys Quantity
6
Insider Buys Sum
$1.01M
Insider Sells Quantity
20
Insider Sells Sum
$26.34M

Insider Activity of Morrison Briggs

According to the SEC Form 4 filings, Morrison Briggs, being in a position of

  1. director at Arvinas, Inc.,
    оver the last 12 months, has bought 20000 shares for $268,070, and sold 0 shares,
    over all time since 2020-03-24, has bought 55000 shares for $685,980, and sold 31714 shares for $2.09M.

Biography of Morrison Briggs

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $268,0701100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-03-06PurchaseArvinas, Inc.
ARVN
director
20,000
0.0307%
$13.40$268,070-36.84%
2025-09-22PurchaseArvinas, Inc.
ARVN
director
30,000
0.0411%
$7.57$227,010+31.87%
2023-08-09SaleSyndax Pharmaceuticals, Inc.
SNDX
director
52,855
0.0754%
$18.27$965,402+8.9%
2023-07-10SaleSyndax Pharmaceuticals, Inc.
SNDX
director
52,855
0.0766%
$20.40$1.08M+0.12%
2023-06-09SaleSyndax Pharmaceuticals, Inc.
SNDX
director
52,855
0.0762%
$21.18$1.12M-2.84%
2023-05-09SaleSyndax Pharmaceuticals, Inc.
SNDX
director
52,855
0.0754%
$21.41$1.13M-3.89%
2023-04-10SaleSyndax Pharmaceuticals, Inc.
SNDX
director
52,855
0.0768%
$19.53$1.03M+5.76%
2023-03-13SaleSyndax Pharmaceuticals, Inc.
SNDX
52,854
0.0765%
$22.53$1.19M-8.97%
2023-02-06SaleSyndax Pharmaceuticals, Inc.
SNDX
52,854
0.077%
$26.83$1.42M-23.11%
2022-09-15SaleSyndax Pharmaceuticals, Inc.
SNDX
President, Head of R&D
66,775
0.1084%
$24.20$1.62M-11.19%
2022-09-14SaleSyndax Pharmaceuticals, Inc.
SNDX
President, Head of R&D
87,645
0.144%
$23.80$2.09M-8.5%
2022-07-01SaleSyndax Pharmaceuticals, Inc.
SNDX
President, Head of R&D
124,584
0.2046%
$19.00$2.37M+20.24%
2022-04-14SaleArvinas, Inc.
ARVN
10,754
0.0202%
$67.03$720,888-36.79%
2022-04-04SaleSyndax Pharmaceuticals, Inc.
SNDX
President, Head of R&D
3,128
0.005%
$18.29$57,220+19.87%
2022-04-01SaleSyndax Pharmaceuticals, Inc.
SNDX
President, Head of R&D
147,090
0.2423%
$17.46$2.57M+30.14%
2022-01-14SaleArvinas, Inc.
ARVN
director
20,960
0.0385%
$65.55$1.37M-29.61%
2021-12-17SaleSyndax Pharmaceuticals, Inc.
SNDX
Chief Executive Officer
70,312
0.1338%
$20.00$1.41M-5%
2021-09-20SaleSyndax Pharmaceuticals, Inc.
SNDX
100
0.0002%
$20.00$2,000-4.95%
2021-09-17SaleSyndax Pharmaceuticals, Inc.
SNDX
140,524
0.2741%
$20.07$2.82M-9.85%
2021-02-08SaleSyndax Pharmaceuticals, Inc.
SNDX
70,312
0.0894%
$13.87$975,526-14.68%
Total: 27
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.